Evidence map›Paper›PMID 20932471›Full record

ArticleMolecular cell2010

CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.

Tarek Abbas, Etsuko Shibata, Jonghoon Park, Sudhakar Jha, Neerja Karnani, Anindya Dutta

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03325517 (Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics), which is not on this map. Cited by 180 papers.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03325517 unknown statusnot on this mapstarted 2017, after this paper: background citation

Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics

TypeobservationalSponsorHeba Momen kamelRan2017 to 2019Enrolled50ConditionsAdenovirus
3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 279 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Macrophage states and polarization duringFrontiers in cellular and infection microbiology · 2026
    Review
  5. Article
  6. SGSS05-NS3, a covalent SETD8 inhibitor that activates p53 pathway in neuroblastoma.Journal of experimental & clinical cancer research : CR · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Genes & development · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tarek AbbasDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA.
Etsuko Shibata
Jonghoon Park
Sudhakar Jha
Neerja Karnani
Anindya Dutta
University of Virginia · US

Funding

Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
The role of MCM8-9 in genomic instability of cancersR01CA060499 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Anindya Dutta · 1994 to 2026
$8.6M
The Role of CRL4-Cdt2 E3 Ubiquitin Ligase in Genomic Stability and CancerR00CA140774 · NCI · UNIVERSITY OF VIRGINIA · PI ABBAS, TAREK A. · 2012 to 2014
$725k
The Role of CRL4-Cdt2 E3 Ubiquitin Ligase in Genomic Stability and CancerK99CA140774 · NCI · UNIVERSITY OF VIRGINIA · PI ABBAS, TAREK A. · 2010 to 2011
$246k
NCI NIH HHS K99 CA140774NCI NIH HHS R00 CA140774NCI NIH HHS R01 CA060499NCI NIH HHS R01 CA60499NCI NIH HHS T32 CA009109PHS HHS KCA140774A
6 · The paper itself

Abstract

PR-Set7/Set8 is a cell-cycle-regulated enzyme that monomethylates lysine 20 of histone H4 (H4K20). Set8 and monomethylated H4K20 are virtually undetectable during G1 and S phases of the cell cycle but increase in late S and in G2. We identify CRL4(Cdt2) as the principal E3 ubiquitin ligase responsible for Set8 proteolytic degradation in the S phase of the cell cycle, which requires Set8-PCNA interaction. Inactivation of the CRL4-Cdt2-PCNA-Set8 degradation axis results in (1) DNA damage and the induction of tumor suppressor p53 and p53-transactivated proapoptotic genes, (2) delayed progression through G2 phase of the cell cycle due to activation of the G2/M checkpoint, (3) specific repression of histone gene transcription and depletion of the histone proteins, and (4) repression of E2F1-dependent gene transcription. These results demonstrate a central role of CRL4(Cdt2)-dependent cell-cycle regulation of Set8 for the maintenance of a stable epigenetic state essential for cell viability.

Indexed as

Cell CycleCell ProliferationChromatin Assembly and DisassemblyProtein Processing, Post-TranslationalAmino Acid SequenceApoptosisCell SurvivalCullin ProteinsDNA DamageDown-RegulationE2F1 Transcription FactorEpigenesis, GeneticHeLa CellsHistone-Lysine N-MethyltransferaseHistonesHumansCullin ProteinsDTL protein, humanE2F1 protein, humanE2F1 Transcription FactorHistone-Lysine N-MethyltransferaseHistonesKMT5A protein, humanNuclear ProteinsProliferating Cell Nuclear AntigenProtein IsoformsTP53 protein, humanTumor Suppressor Protein p53Ubiquitin-Protein Ligases

Identifiers

PMID20932471
PMCPMC2966975
OpenAlexW1994792930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.